-The Hindu Women are essential for the success of schemes like the mid-day meal programme. Improving their wages and working conditions would be better than blaming them when things go wrong. Mahatma Gandhi once declared, "A nation's greatness is measured by how it treats its weakest members." By this yardstick, India does not fare well. Consider recent headlines alone: 23 Bihari children die after eating poisoned midday meals at their schools. Six-year-old...
More »SEARCH RESULT
Private healthcare 20 times costlier than public healthcare: study -Kundan Pandey
-Down to Earth Despite high cost of treatment, private sector still takes care of 80 per cent of all outpatient care and about 60 per cent of all inpatient care A study on healthcare costs in India has reaffirmed what everyone knows-that private hospitals are not affordable for the common man. Getting treatment in these hospitals is at least 20 times costlier than the healthcare provided in district government hospitals, reveals the...
More »Ahead of World Hepatitis Day, UN urges greater efforts to fight ‘silent epidemic’
-The United Nations Only one-third of the world's countries have national strategies for viral hepatitis, the United Nations health agency today said urging Governments to scale up measures to tackle this ‘silent epidemic,' in particular the five types that, over time, cause chronic and debilitating illnesses. "The fact that many hepatitis B and C infections are silent, causing no symptoms until there is severe damage to the liver, points to the urgent...
More »The malnutrition bazaar-Kundan Pandey
-Down to Earth Is India ready to protect itself from the onslaught of food and nutrition industry? India is shouldering a huge burden of malnutrition-in the absence of government figures, a dipstick survey by non-profit HUNGaMA in 2012 suggests that 59 per cent of the country's children could have stunted growth and 42 per cent could be underweight. While the government is still struggling to tackle the problem, the food and nutrition...
More »Price control, IP Act & regulatory framework: Revisiting some imp issues about Indian pharma-Ramesh Adige
-The Economic Times Over a year ago, I had written a piece, Quo Vadis, Indian Pharma? (ET, May 11, 2012), in this column. Some key issues were highlighted in the article. Perhaps it is time to revisit the subject and bring out some current issues. Price control: Hurray, the department of pharmaceuticals has come out with a new non-intrusive price control methodology, moving from the cost-based model to the average market price...
More »